CareLit · DOI-Nachweis · Aktuelle Neurologie
Botulinum toxin (BoNT) in headache disorders
DOI 10.1055/s-0031-1276544
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS. Silberstein
ZeitschriftAktuelle Neurologie
Ausgabe04/2011
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Headache disorders, including migraine and chronic migraine (headaches ≥15 days/month and a link to migraine) are common debilitating conditions that profoundly impact quality of life. There are 7 BoNT serotypes (A, B, C1, D, E, F, and G). Botulinum toxin type A (BoNTA) has been the most widely studied serotype for therapeutic purposes. Several randomized, double-blind, placebo-controlled studies support the efficac…
Zitieren
Zitierempfehlung
S. Silberstein (2011) Botulinum toxin (BoNT) in headache disorders. Aktuelle Neurologie (04). https://doi.org/10.1055/s-0031-1276544
Mit CareLit weiterarbeiten